<DOC>
	<DOC>NCT00826163</DOC>
	<brief_summary>We hypothesize that ongoing and more severe airway inflammation in COPD may result from the impairment in activation of innate immune response</brief_summary>
	<brief_title>Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>clinical diagnosis of COPD or asthma a ratio of prebronchodilator FEV1 to forced vital capacity (FVC) equal to or less than 0.70 postbronchodilator FEV1 &gt; or = 50% predicted Exacerbation systemic corticosteroids DM, HIV and autoimmune disease immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>